Even with universal health care, patients living with cancer often face substantial treatment-related costs and income loss in Europe.
Insights into the socioeconomic impact of cancer within and across countries are needed to create awareness, inform policy, and develop targeted measurement instruments.
The SEC study aims to explore the socioeconomic impact and financial toxicity of cancer and identify vulnerable patient groups across Europe.
